Skip to main content

Cardlytics, Inc.

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

CDLX$1.63-10.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders' Deficit (Unaudited)

Nine Months Ended September 30, 2026:

AdditionalPaid-InCapital(1) · AccumulatedOtherComprehensive (Loss) Income · AccumulatedDeficit · Total
Common Stock(1)
Shares · Amount
Balance – December 31, 20255,451$1$1,399,551$(1,996)$(1,404,064)$(6,508)
Stock-based compensation——10,713——10,713
Settlement of restricted stock459—————
Issuance of common stock pursuant to the 2018 ESPP (as defined below)12—66——66
Other comprehensive income———1,008—1,008
Net loss————(28,303)(28,303)
Balance – September 30, 20265,922$1$1,410,330$(988)$(1,432,367)$(23,024)

Three Months Ended September 30, 2026:

AdditionalPaid-InCapital(1) · AccumulatedOtherComprehensive Loss · AccumulatedDeficit · Total
Common Stock(1)
Shares · Amount
Balance – June 30, 20265,808$1$1,408,091$(676)$(1,423,420)$(16,004)
Stock-based compensation——2,239——2,239
Settlement of restricted stock114—————
Other comprehensive loss———(312)—(312)
Net loss————(8,947)(8,947)
Balance – September 30, 20265,922$1$1,410,330$(988)$(1,432,367)$(23,024)

(1)The number of shares of common stock and additional paid-in capital amounts have been adjusted for the prior period presented to reflect the one-for-ten reverse stock split effected on June 5, 2026. See Note 2 -Significant Accounting Policies and Recent Accounting Standards for more information.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (UNAUDITED)

Nine Months Ended September 30, 2025:

AdditionalPaid-InCapital(1) · AccumulatedOtherComprehensive Income (Loss) · AccumulatedDeficit · Total
Common Stock(1)
Shares · Amount
Balance – December 31, 20245,126$1$1,366,967$3,601$(1,300,576)$69,993
Stock-based compensation——25,733——25,733
Settlement of restricted stock228—————
Issuance of common stock pursuant to the 2018 ESPP (as defined below)26—447——447
Other comprehensive loss———(5,639)—(5,639)
Net loss————(95,238)(95,238)
Balance – September 30, 20255,380$1$1,393,147$(2,038)$(1,395,814)$(4,704)

Three Months Ended September 30, 2025:

AdditionalPaid-InCapital(1) · AccumulatedOtherComprehensive (Loss) Income · AccumulatedDeficit · Total
Common Stock(1)
Shares · Amount
Balance – June 30, 20255,299$1$1,385,474$(3,628)$(1,323,141)$58,706
Stock-based compensation——7,673——7,673
Settlement of restricted stock81—————
Other comprehensive income———1,590—1,590
Net loss————(72,673)(72,673)
Balance – September 30, 20255,380$1$1,393,147$(2,038)$(1,395,814)$(4,704)

(1)The number of shares of common stock and additional paid-in capital amounts have been adjusted for the prior period presented to reflect the one-for-ten reverse stock split effected on June 5, 2026. See Note 2 -Significant Accounting Policies and Recent Accounting Standards for more information.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.